Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors.

Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML.

J Cell Biol. 2005 May 23;169(4):681-91.

2.

Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.

Vempati P, Popel AS, Mac Gabhann F.

Cytokine Growth Factor Rev. 2014 Feb;25(1):1-19. doi: 10.1016/j.cytogfr.2013.11.002. Epub 2013 Nov 27. Review.

3.

[The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].

Fink K, Boratyński J.

Postepy Hig Med Dosw (Online). 2012 Sep 10;66:609-28. Review. Polish.

4.

Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.

Stalmans I.

Verh K Acad Geneeskd Belg. 2005;67(4):229-76. Review.

PMID:
16334858
5.

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.

Shinkaruk S, Bayle M, Laïn G, Déléris G.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.

PMID:
12678905
6.

Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.

Pradeep CR, Sunila ES, Kuttan G.

Integr Cancer Ther. 2005 Dec;4(4):315-21. Review.

PMID:
16282508
7.

Vascular endothelial growth factor and its receptors.

Klagsbrun M, D'Amore PA.

Cytokine Growth Factor Rev. 1996 Oct;7(3):259-70. Review.

PMID:
8971481
8.

VEGF as a key mediator of angiogenesis in cancer.

Carmeliet P.

Oncology. 2005;69 Suppl 3:4-10. Epub 2005 Nov 21. Review.

PMID:
16301830
9.

[Interregulation of VEGF/R endostatin and MMP in the angiogenesis of hematologic malignancies--review].

Zhang JD, Zhang Y.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Dec;13(6):1145-50. Review. Chinese.

PMID:
16403301
10.

Inhibition of vascular endothelial growth factor receptor signaling in angiogenic tumor vasculature.

Backer MV, Hamby CV, Backer JM.

Adv Genet. 2009;67:1-27. doi: 10.1016/S0065-2660(09)67001-2. Review.

PMID:
19914448
11.

VEGF-A: a critical regulator of blood vessel growth.

Ferrara N.

Eur Cytokine Netw. 2009 Dec;20(4):158-63. doi: 10.1684/ecn.2009.0170. Review.

12.

Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.

Brown LF, Detmar M, Claffey K, Nagy JA, Feng D, Dvorak AM, Dvorak HF.

EXS. 1997;79:233-69. Review.

PMID:
9002222
13.

Tumor Stroma, Tumor Blood Vessels, and Antiangiogenesis Therapy.

Dvorak HF.

Cancer J. 2015 Jul-Aug;21(4):237-43. doi: 10.1097/PPO.0000000000000124. Review.

PMID:
26222073
14.
15.

Molecular mechanisms of tumor angiogenesis.

Lutsenko SV, Kiselev SM, Severin SE.

Biochemistry (Mosc). 2003 Mar;68(3):286-300. Review.

PMID:
12733970
16.

Targeted in vivo imaging of angiogenesis: present status and perspectives.

Choe YS, Lee KH.

Curr Pharm Des. 2007;13(1):17-31. Review.

PMID:
17266586
17.

Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature.

Deryugina EI, Quigley JP.

Matrix Biol. 2015 May-Jul;44-46:94-112. doi: 10.1016/j.matbio.2015.04.004. Epub 2015 Apr 22. Review.

18.

MicroRNA control of vascular endothelial growth factor signaling output during vascular development.

Dang LT, Lawson ND, Fish JE.

Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):193-200. doi: 10.1161/ATVBAHA.112.300142. Review.

20.

[The role of vascular endothelial growth factor in inflammatory processes].

Koczy-Baron E, Kasperska-Zając A.

Postepy Hig Med Dosw (Online). 2014 Jan 23;68:57-65. doi: 10.5604/17322693.1086360. Review. Polish.

Supplemental Content

Support Center